PEAK6 Investments’s Outset Medical OM Stock Holding History

PEAK6 Investments’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-987	Closed	-$220K	–	5782
2022 Q2	$220K	Buy	+987	New	+$425K	﹤0.01%	4680

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

EHI

Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Investments's OM Position: Q4 2022 in Review

PEAK6 Investments sold out of Outset Medical (OM) in Q4 2022, closing a stake of 5,062 shares — an estimated $1.21M sold.

PEAK6 Investments first reported a position in OM in Q2 2022 and held it in 2 quarters. The position peaked at $1.32M in Q2 2022. 152 funds tracked by Wall St. Rank hold OM as of Q4 2022.

PEAK6 Investments reported no remaining Outset Medical position as of Q4 2022 after selling out during the quarter.
PEAK6 Investments sold 5,062 Outset Medical shares in Q4 2022, an estimated $1.21M.
PEAK6 Investments first reported a position in Outset Medical in Q2 2022 and held it in 2 quarters.
PEAK6 Investments's Outset Medical position peaked at $1.32M in Q2 2022.
152 funds tracked by Wall St. Rank held Outset Medical as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.